Table of Contents

company-logo

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.

Insmed Dividend Announcement

• Insmed does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Insmed dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Insmed Dividend History

Insmed Dividend Yield

Insmed current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Insmed stock? Use our calculator to estimate your expected dividend yield:

Insmed Financial Ratios

P/E ratio-14.44
PEG ratio5.49
P/B ratio25.81
ROE1259.44%
Payout ratio0.00%
Current ratio6.37
Quick ratio5.99
Cash Ratio1.78

Insmed Dividend FAQ

Does Insmed stock pay dividends?
Insmed does not currently pay dividends to its shareholders.
Has Insmed ever paid a dividend?
No, Insmed has no a history of paying dividends to its shareholders. Insmed is not known for its dividend payments.
Why doesn't Insmed pay dividends?
There are several potential reasons why Insmed would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Insmed ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Insmed has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Insmed a dividend aristocrat?
Insmed is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Insmed a dividend king?
Insmed is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Insmed a dividend stock?
No, Insmed is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Insmed stocks?
To buy Insmed you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Insmed stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.